Showing results (181-190 of 252) with videos related to

Sort By:
Pageof 26
Haematologica|November 27, 2025
Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment for Tropheryma whippleiTeresa Antonia Kiener, Gregor Schweighofer-Zwink, Gundula Rendl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2018
Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal CancerPierre Laurent-Puig, Marie-Lise Grisoni, Volker Heinemann, et al.
Molecular Biology Reports|December 27, 2024
Prognostic and functional role of the nuclear export receptor 1 (XPO1) in gastrointestinal cancers: a potential novel target?Viktorija Sokolova, Rebecca Gruber, Lorenz M Pammer, et al.
Oncotarget|November 17, 2012
Pyruvate kinase is a dosage-dependent regulator of cellular amino acid homeostasisKatharina Bluemlein, Matthias Glückmann, Nana-Maria Grüning, et al.
Gut|December 20, 2014
Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulationBarbara Behm, Pietro Di Fazio, Patrick Michl, et al.
Molecular Carcinogenesis|September 27, 2014
MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patientsAnna Lena Ress, Verena Stiegelbauer, Elke Winter, et al.
Frontiers in Bioscience (Elite Edition)|January 4, 2011
Respiratory chain complex I is a mitochondrial tumor suppressor of oncocytic tumorsFranz A Zimmermann, Johannes A Mayr, Rene Feichtinger, et al.
The Journal of Pathology|December 17, 2014
Under-expression of α8 integrin aggravates experimental atherosclerosisCarlos Menendez-Castro, Nada Cordasic, Daniel Neureiter, et al.
Frontiers in Bioscience (Elite Edition)|January 4, 2011
Heterogeneity of mitochondrial energy metabolism in classical triphasic Wilms' tumorRene G Feichtinger, Daniel Neureiter, Brigitte Royer-Pokora, et al.
BMC Cancer|October 18, 2015
CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancerThomas Melchardt, Clemens Hufnagl, Teresa Magnes, et al.
Pageof 26